TANYA MARR: Open Payments
NPI 1508205550 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 91 payments from 29 companies in 2025. Trend: 2023 $2,374 · 2024 $1,800 · 2025 $1,724
Food & beverage: $1,624Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $196 |
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| E.R. Squibb & Sons, L.L.C. | 14 | $155 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| SEAGEN INC. | 1 | $100 |
| Aimmune Therapeutics, Inc. | 1 | $96 |
| PFIZER INC. | 6 | $79 |
| Genentech USA, Inc. | 4 | $77 |
| Daiichi Sankyo Inc. | 3 | $73 |
| ADC THERAPEUTICS AMERICA, INC. | 4 | $71 |
Products named: KEYTRUDA, RYBREVANT, ZENPEP, OPDUALAG, OPDIVO, Enhertu, ZYNLONTA, DANZITEN.
Industry payments across NY — which companies pay providers there.
